Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-05

Clinical Trial Update: s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for s086 tablets in mild to moderate essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • s086 tablets

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Essential Hypertension | Phase 2 | Status: UNKNOWN